Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer

Human Gene Therapy

Volumn 12, Issue 2, 2001, Pages 149-160

  Oshikawa, K ^a,b   Rakhmilevich, A L ^c   Shi, F ^a   Sondel, P M ^c   Yang, N S ^c,d   Mahvi, D M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF WISCONSIN   (United States)

^d AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; GELATINASE B; INTERFERON ANTIBODY; INTERLEUKIN 12; MESSENGER RNA; MONOCLONAL ANTIBODY; PLASMID DNA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER SURGERY; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; SKIN TUMOR;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; IMMUNITY, CELLULAR; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPH NODES; LYMPHOKINES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; T-LYMPHOCYTES, CYTOTOXIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0035915810     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750061212     Document Type: Article

References (43)

1. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
2. Matrix metalloproteinase inhibitors
3. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
4. Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12
5. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma
6. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12
7. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
8. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients
9. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer
10. Amount of interleukin 12 available at the tumor site is critical for tumor regression
11. IL-12 regulated VEGF and MMPs in a murine breast cancer model
12. Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12
13. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)
14. + T cells through IL-12 produced by Listeria-induced macrophages
15. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
16. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
17. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma
18. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
19. Cancer trial of interleukin-12 halted
20. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes
21. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes
22. High cytokine production and effective antitumor activity of a recombinant vaccine virus encoding murine interleukin 12
23. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes
24. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production
25. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinominal gene therapy using IL-12, pro-IL-18, and IL-1β converting enzyme cDNA
26. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells
27. Antimetastatic vaccination against Lewis lung carcinoma with antilogous tumor cells modified to express murine interleukin 12
28. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors
29. Response of human natural killer (NK) cells to NK cell stemuratory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
30. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines
31. Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA
32. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF
33. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus
34. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
35. Liver NK 1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
36. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model
37. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor
38. IL-12 induces T helper 1-directed antitumor response
39. Inhibition of angiogenesis in vivo by interleukin 12
40. Interleukin-12 gene transfer results in CD8-dependent regression of murine CT26 liver tumors
41. Accurate identification of experimental pulmonary metastases
42. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells
43. Cancer Immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts